itraconazole has been researched along with ascorbic acid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Bae, SK; Kim, EY; Mun, JH; Park, SJ; Shim, EJ; Shin, JG; Shon, JH | 1 |
Daintree, LS; Ding, S; Han, J; Ledger, DM; Qi, J; Wang, B; Wu, W; Yin, X; Zhao, W | 1 |
Attia, DA; Elmazar, MM; Elmowafy, E; Lamie, C; Mortada, ND | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Arulmoli, T; Chidananda, N; Kumari, NS; Poojary, B; Shetty, P; Sumangala, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Agafonova, NA; Borisevich, SS; Burgart, YV; Chupakhin, ON; Evstigneeva, NP; Gerasimova, NA; Krasnykh, OP; Kungurov, NV; Kushch, SO; Makhaeva, GF; Maslova, VV; Rudakova, EV; Saloutin, VI; Shchegolkov, EV; Solodnikov, SY; Triandafilova, GA; Ulitko, MV; Zilberberg, NV | 1 |
1 review(s) available for itraconazole and ascorbic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for itraconazole and ascorbic acid
Article | Year |
---|---|
Increased oral bioavailability of itraconazole and its active metabolite, 7-hydroxyitraconazole, when coadministered with a vitamin C beverage in healthy participants.
Topics: Adult; Antifungal Agents; Ascorbic Acid; Beverages; Biological Availability; Biotransformation; Cross-Over Studies; Female; Food-Drug Interactions; Half-Life; Humans; Itraconazole; Male; Miconazole; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Young Adult | 2011 |
5 other study(ies) available for itraconazole and ascorbic acid
Article | Year |
---|---|
Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Topics: Administration, Oral; Animals; Antifungal Agents; Ascorbic Acid; Biological Availability; Chemistry, Pharmaceutical; Dogs; Drug Compounding; Excipients; Hydrogen-Ion Concentration; Hypromellose Derivatives; Itraconazole; Male; Microscopy, Electron, Scanning; Poloxamer; Solubility | 2015 |
Diversifying the skin cancer-fighting worthwhile frontiers: How relevant are the itraconazole/ascorbyl palmitate nanovectors?
Topics: Animals; Ascorbic Acid; Itraconazole; Mice; Skin Absorption; Skin Neoplasms | 2022 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Facile synthesis, characterization and pharmacological activities of 3,6-disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 5,6-dihydro-3,6-disubstituted-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Biphenyl Compounds; Chemistry Techniques, Synthetic; Free Radical Scavengers; Picrates; Rats; Thiadiazoles; Triazoles | 2012 |
Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
Topics: Animals; Bacteria; Drug Screening Assays, Antitumor; Epidermophyton; HeLa Cells; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Trichophyton | 2020 |